RE: More brilliant news!1 Oct 2020 22:33
It is known the MHRA requires a specificity of greater than 98% for rapid antibody tests which adds weight to the likelihood of Omega Diagnostics and the UK RTC receiving the approval needed for home-use of the antibody test. However, with 97.7% sensitivity the question mark remains if it will meet the adjacent sensitivity MHRA guidelines that are also greater than 98%.
Could this be why we haven’t had MHRA update?